HRT Financial’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

HRT Financial’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,826	Closed	-$2.13M	–	3857
2021 Q1	$2.13M	Buy	+9,826	New	+$1.85M	0.02%	581
2020 Q3	–	Sell	-2,158	Closed	-$264K	–	2547
2020 Q2	$264K	Buy	+2,158	New	+$245K	0.01%	1042
2019 Q3	–	Sell	-1,517	Closed	-$261K	–	1683
2019 Q2	$261K	Buy	+1,517	New	+$262K	0.02%	577

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

HRT Financial's GWPH Position: Q2 2021 in Review

HRT Financial sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 9,826 shares — an estimated $2.13M sold.

HRT Financial first reported a position in GWPH in Q2 2019 and held it in 3 quarters. The position peaked at $2.13M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

HRT Financial reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
HRT Financial sold 9,826 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $2.13M.
HRT Financial first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 3 quarters.
HRT Financial's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.13M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.